Loading...

Brilliant Violet 605™ anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_BV605_CD3_Antibody_FC_043013
C57BL/6 mouse splenocytes were stained with CD19 APC and CD3 (clone 17A2) Brilliant Violet 605™.
  • 17A2_BV605_CD3_Antibody_FC_043013
    C57BL/6 mouse splenocytes were stained with CD19 APC and CD3 (clone 17A2) Brilliant Violet 605™.
Compare all formats See Brilliant Violet 605™ spectral data
Cat # Size Price Save
100237 125 µL ¥45,980
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605™ under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Yu‐Han Chang et al. 2017. Immunity. 47(5):943-958 . PubMed
  2. Chandran S, et al. 2020. Front Immunol. 11:787. PubMed
  3. Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
  4. Pettini E, et al. 2021. Vaccines (Basel). 9:. PubMed
  5. Mancini M, et al. 2021. Sci Rep. 11:21171. PubMed
  6. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  7. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  8. Merk VM, et al. 2023. Genes Immun. 24:52. PubMed
  9. Dickerson KM, et al. 2022. Blood Cancer Discov. 3:240. PubMed
  10. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  11. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  12. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  13. Dijkman K, et al. 2023. NPJ Vaccines. 8:66. PubMed
  14. Tata A, et al. 2021. Oncoimmunology. 10:1933808. PubMed
  15. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  16. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  17. Mancini M, et al. 2019. J Immunol. 202:1479. PubMed
  18. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  19. Pokrovskii M, et al. 2019. Immunity. 51:185. PubMed
  20. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  21. Wabitsch S, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1166. PubMed
  22. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  23. Israelow B, et al. 2021. Sci Immunol. 6:eabl4509. PubMed
  24. Yu X, et al. 2021. Nature. 594:560. PubMed
  25. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  26. Stein RR, et al. 2018. Elife. 7:e30916. PubMed
  27. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  28. Böttcher JP, et al. 2018. Cell. 172:1022. PubMed
  29. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  30. An J, et al. 2022. iScience. 25:103570. PubMed
  31. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  32. McBride KM, et al. 2019. Front Oncol. 9:517. PubMed
  33. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  34. Camell CD, et al. 2020. Cell Metabolism. 30(6):1024-1039.e6.. PubMed
  35. Schuldt N, et al. 2015. PLoS One. 10: 0145762. PubMed
  36. Zhang W, et al. 2022. Nat Methods. 19:759. PubMed
  37. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  38. Breznik JA, et al. 2021. The Journal of Physiology. 599(8):2169-2195. PubMed
  39. Lee SC et al. 2018. Cancer cell. 34(2):225-241 . PubMed
  40. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  41. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  42. Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
  43. Voigt A, et al. 2015. Biol Open. 10.1242/bio.013771. PubMed
  44. Alam IS, et al. 2020. Cancer Res. 80:4780. PubMed
  45. Ryu S, et al. 2021. eLife. 0.416666666666667. PubMed
  46. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  47. Lee CH, et al. 2018. Elife. 7:e32532. PubMed
  48. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
  49. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  50. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
RRID
AB_2562039 (BioLegend Cat. No. 100237)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 05/01/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account